NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 76 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q1 2015. The put-call ratio across all filers is 4.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $540,000 | -3.1% | 994,696 | +3.8% | 0.00% | – |
| Q2 2016 | $557,000 | -40.3% | 958,415 | +50.0% | 0.00% | – |
| Q1 2016 | $933,000 | -53.2% | 638,982 | +2.6% | 0.00% | -100.0% |
| Q4 2015 | $1,994,000 | -48.4% | 622,971 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $3,862,000 | -82.1% | 617,926 | -71.6% | 0.00% | -83.3% |
| Q2 2015 | $21,625,000 | +135.3% | 2,177,695 | +74.6% | 0.01% | +100.0% |
| Q1 2015 | $9,191,000 | +59.6% | 1,247,090 | +15.9% | 0.00% | +50.0% |
| Q4 2014 | $5,757,000 | +35.1% | 1,076,166 | +27.0% | 0.00% | +100.0% |
| Q3 2014 | $4,261,000 | -24.7% | 847,129 | +0.4% | 0.00% | -50.0% |
| Q2 2014 | $5,661,000 | +28.0% | 843,717 | +38.2% | 0.00% | +100.0% |
| Q1 2014 | $4,421,000 | +88.9% | 610,702 | -1.6% | 0.00% | 0.0% |
| Q4 2013 | $2,340,000 | – | 620,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 9,379,987 | $69,131,000 | 9.82% |
| Family Management Corp | 82,875 | $611,000 | 0.28% |
| Montecito Bank & Trust | 75,717 | $558,000 | 0.28% |
| Bedell Frazier Investment Counselling, LLC | 62,825 | $463,000 | 0.19% |
| Lyons Wealth Management, LLC. | 20,000 | $147,000 | 0.16% |
| Price Capital Management, Inc. | 28,864 | $213,000 | 0.13% |
| BOLTON LP | 50,000 | $369,000 | 0.10% |
| BOLTON LP | 50,000 | $369,000 | 0.10% |
| WEDBUSH SECURITIES INC | 76,500 | $564,000 | 0.10% |
| HYMAN CHARLES D | 43,375 | $320,000 | 0.05% |